VI.2 Elements for a Public Summary

Share "VI.2 Elements for a Public Summary"

N/A

Protected

Ano acadêmico: 2023

Info

Descarregar agora

Protected

Academic year: 2023

Share "VI.2 Elements for a Public Summary"

Copied!

Carregando.... (Ver texto completo agora)

Descarregar agora ( 8 páginas )

Texto

Referências

Descarregar agora ( PDF - 8 páginas - 312.85 KB )

Documentos relacionados

Part VI: Summary of the risk management plan

Risk minimisation measures Routine risk communication: None Routine risk minimisation activities recommending specific clinical measures to address the risk: None Other routine

Documentos relacionados

Summary of risk management plan for Progedex 25mg Injektionslösung (progesterone)

1 Elements for a Public Summary

VI.2 ELEMENTS FOR A PUBLIC SUMMARY

Page 14 of 37 VI.2 Elements for a public summary

VI.2 Elements for a Public Summary

Part VI Summary of the risk management plan

VI.2

Gefitinib helps blocking a protein called 'Epidermal Growth Factor Receptor' (EGFR), which is involved in the growth and spread of cancer cells